Articles

Quick View: Launch Of Critical Medicines Alliance Will Mitigate Drug Shortages And Promote Local Pharmaceutical Production In The EU

Pharmaceuticals / Europe / Fri 19 Jan, 2024

The Latest: On January 16 2024, the European Commission’s Health Emergency Preparedness and Response Authority launched an open call for expression of interest to join the Critical Medicines Alliance (CMA). This represents the first major step towards the founding of the alliance which is planned to address drug shortages at the EU level. In

Read More

Spanish Political Divisions Threaten Policy-Making Process

Country Risk / Spain / Fri 19 Jan, 2024

Key View

  • We anticipate that Prime Minister Pedro Sanchez and his government will continue to face difficulties passing legislation as ideological differences and the lack of a majority obstructs the policymaking process.
  • Podemos’ exit from the government means that policy in areas such as labour will be especially complicated.
  • The divisions
Read More

Quick View: Lupin Achieves Three New Generic Approvals In The US Highlighting Continued Interest In Expanding Generics Portfolio

Pharmaceuticals / United States / Thu 18 Jan, 2024

The Latest: On January 14 2024, Lupin announced that it had received US FDA approval to market a generic version of propranolol hydrochloride extended-release capsules, used in the treatment of migraine and hypertension. The approval is significant as Lupin can offer a more affordable alternative to ANI Pharmaceuticals' Inderal LA extended

Read More
Download Indicator Summary
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Clearbit Form
 

Thank you. Your download link will be emailed to you shortly.